NASDAQ:RNA
Avidity Biosciences, Inc.
- Stock
Last Close
29.51
16/05 20:00
Market Cap
956.16M
Beta: −0.10
Volume Today
1.04M
Avg: 1.32M
PE Ratio
−4.46
PFCF: −4.85
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
net income | -11.22M - | -24.73M 120.52% | -44.35M 79.33% | -118.01M 166.06% | -174.00M 47.44% | -212.22M 21.97% | |
depreciation and amortization | 383K - | 348K 9.14% | 373K 7.18% | 639K 71.31% | 1.39M 117.06% | 2.10M 51.48% | |
deferred income tax | 84K - | -1.77M - | |||||
stock based compensation | 60K - | 406K 576.67% | 4.31M 961.58% | 17.06M 295.73% | 27.14M 59.12% | 38.22M 40.84% | |
change in working capital | 671K - | 19.12M 2,749.93% | 2.33M 87.81% | 5.34M 128.90% | 9.82M 83.89% | 61.13M 522.75% | |
accounts receivables | |||||||
inventory | |||||||
accounts payables | 451K - | 5.75M 1,174.72% | 6.04M 5.11% | 18.32M 203.08% | 1.77M 90.34% | ||
other working capital | 671K - | 18.67M 2,682.71% | -3.42M 118.30% | -705K 79.37% | -8.50M 1,105.53% | 59.36M 798.44% | |
other non cash items | 447K - | 7.35M 1,543.62% | 139K 98.11% | 163K 17.27% | -615K 477.30% | -6.53M 961.30% | |
net cash provided by operating activities | -9.65M - | 2.49M 125.79% | -37.12M 1,590.64% | -94.81M 155.44% | -136.27M 43.72% | -119.06M 12.63% | |
investments in property plant and equipment | -49K - | -235K 379.59% | -1.09M 364.68% | -3.74M 242.49% | -2.82M 24.52% | -4.23M 49.77% | |
acquisitions net | 82.52M - | 187.13M 126.78% | |||||
purchases of investments | -6.69M - | -85.36M 1,175.32% | -355.84M 316.88% | -461.00M 29.55% | |||
sales maturities of investments | 6.58M - | 168.71M 2,463.91% | 335.16M 98.67% | ||||
other investing activites | -82.52M - | -187.13M 126.78% | |||||
net cash used for investing activites | -49K - | -235K 379.59% | -7.79M 3,212.77% | -82.52M 959.95% | -189.96M 130.20% | -130.07M 31.53% | |
debt repayment | -2.80M - | -4.68M 67.25% | |||||
common stock issued | 65K - | 298.08M 458,484.62% | 185.94M 37.62% | 344.78M 85.43% | 93.86M 72.78% | ||
common stock repurchased | 444K - | ||||||
dividends paid | -106K - | -444K 318.87% | |||||
other financing activites | 92.07M - | -21.36M 123.20% | -9.62M 54.95% | 1.39M 114.47% | |||
net cash used provided by financing activities | 5.14M - | 89.23M 1,634.70% | 272.04M 204.86% | 176.32M 35.19% | 346.17M 96.34% | 93.86M 72.89% | |
effect of forex changes on cash | -44K - | ||||||
net change in cash | -4.56M - | 91.49M 2,106.32% | 227.13M 148.27% | -1.01M 100.45% | 19.95M 2,067.26% | -155.31M 878.59% | |
cash at beginning of period | 7.65M - | 3.09M 59.61% | 94.58M 2,960.78% | 321.71M 240.16% | 320.70M 0.32% | 340.40M 6.14% | |
cash at end of period | 3.09M - | 94.58M 2,960.78% | 321.71M 240.16% | 320.70M 0.32% | 340.65M 6.22% | 185.08M 45.67% | |
operating cash flow | -9.65M - | 2.49M 125.79% | -37.12M 1,590.64% | -94.81M 155.44% | -136.27M 43.72% | -119.06M 12.63% | |
capital expenditure | -49K - | -235K 379.59% | -1.09M 364.68% | -3.74M 242.49% | -2.82M 24.52% | -4.23M 49.77% | |
free cash flow | -9.70M - | 2.25M 123.24% | -38.21M 1,794.41% | -98.55M 157.93% | -139.09M 41.13% | -123.29M 11.36% |
All numbers in USD (except ratios and percentages)